In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.